SOURCE: Biodel, Inc.

Biodel, Inc.

September 22, 2015 07:00 ET

Biodel to Present at the Ladenburg Thalmann 2015 Healthcare Conference

DANBURY, CT--(Marketwired - September 22, 2015) - Biodel Inc. (NASDAQ: BIOD) management will be presenting an overview of the Company's technologies, development programs, and outlook at the Ladenburg Thalmann 2015 Healthcare Conference being held in New York City at The Sofitel Hotel on September 29, 2015. Interested parties can access a link to a live webcast of the presentation from the News & Events section of the Biodel website, The corporate presentation of the Company will take place on Tuesday, September 29, 2015 at 11:00 a.m. ET. A live and archived webcast of the presentation will be accessible on the Biodel website at under "Webcasts" in the "News & Events" section.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. Biodel's product candidates are developed by applying proprietary technologies to existing drugs in order to improve their therapeutic profiles. More information about Biodel is available at


Contact Information

    Clayton Robertson
    +1 (646) 378 2964